Microbial tolerance in secondary peritonitis is dose dependent

Cellular Immunology

Volumn 258, Issue 1, 2009, Pages 98-106

  Lenz, Andreas M ^a,b   Turina, Matthias ^b,c   Alard, Pascale ^b   Gardner, Sarah A ^b   Cheadle, William G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cytokines; Ex vivo; In vitro; Inflammation; Klebsiella; Macrophages; Murine; Peritonitis; Tolerance

Indexed keywords

GENTAMICIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; EX VIVO STUDY; KLEBSIELLA; MALE; MICROBIOLOGICAL EXAMINATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; GENTAMICINS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PERITONITIS;

ANIMALIA; BACTERIA (MICROORGANISMS); KLEBSIELLA; MURINAE; MUS;

EID: 67349168437     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.03.018     Document Type: Article

References (59)

1. Calandra T., and Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care Med. 7 (2005) 1538-1548
2. Marshall J.C. Intra-abdominal infections. Microbes. Infect. 11 (2004) 1015-1025
3. Bosscha K., van Vroonhoven T.J., and van der W.C. Surgical management of severe secondary peritonitis. Br. J. Surg. 11 (1999) 1371-1377
4. Marshall J.C., Christou N.V., and Meakins J.L. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann. Surg. 2 (1993) 111-119
5. Koperna T., and Schulz F. Prognosis and treatment of peritonitis. Do we need new scoring systems?. Arch. Surg. 2 (1996) 180-186
6. Evans H.L., Raymond D.P., Pelletier S.J., Crabtree T.D., Pruett T.L., and Sawyer R.G. Diagnosis of intra-abdominal infection in the critically ill patient. Curr. Opin. Crit. Care 2 (2001) 117-121
7. Cavaillon J.M., Adrie C., Fitting C., and Adib-Conquy M. Reprogramming of circulatory cells in sepsis and SIRS. J. Endotoxin. Res. 5 (2005) 311-320
8. Munoz C., Carlet J., Fitting C., Misset B., Bleriot J.P., and Cavaillon J.M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 5 (1991) 1747-1754
9. Schinkel C., Sendtner R., Zimmer S., and Faist E. Functional analysis of monocyte subsets in surgical sepsis. J. Trauma 5 (1998) 743-748
10. Cavaillon J.M., and Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 5 (2006) 233
11. Beeson P.B. Tolerance to bacterial pyrogens. I. Factors influencing its development. J. Exp. Med. 29 (1947)
12. Greisman S.E., Young E.J., and Carozza Jr. F.A. Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 6 (1969) 1223-1236
13. Medvedev A.E., Sabroe I., Hasday J.D., and Vogel S.N. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin. Res. 3 (2006) 133-150
14. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes. Infect. 9 (2002) 903-914
15. Jin M.S., and Lee J.O. Structures of the toll-like receptor family and its ligand complexes. Immunity 2 (2008) 182-191
16. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. (2006) 1-16
17. Dobrovolskaia M.A., Medvedev A.E., Thomas K.E., Cuesta N., Toshchakov V., Ren T., Cody M.J., Michalek S.M., Rice N.R., and Vogel S.N. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J. Immunol. 1 (2003) 508-519
18. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 7164 (2007) 819-826
19. Woods D.R., Peyton J.C., Franklin G.A., Turina M., and Cheadle W.G. Decreased neutrophil response in a model of chronic intraperitoneal Klebsiella infection. Surg. Infect. (Larchmt.) 3 (2007) 367-376
20. Brook I. Microbiology and management of abdominal infections. Dig. Dis. Sci. 10 (2008) 2585-2591
21. Schurr J.R., Young E., Byrne P., Steele C., Shellito J.E., and Kolls J.K. Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect. Immun. 1 (2005) 532-545
22. Wu J.H., Hong L.C., Tsai Y.Y., Chen H.W., Chen W.X., and Wu T.S. Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae. Cell Microbiol. 9 (2006) 1467-1474
23. Lenz A.M., Franklin G.A., Fairweather M., McClintock M.L., Jala V.R., Peyton J.C., Gardner S.A., and Cheadle W.G. Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis. Cytokine 3 (2007) 207-215
24. Zhang X., and Morrison D.C. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukoc. Biol. 5 (1993) 444-450
25. Fujiwara N., and Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 3 (2005) 281-286
26. Roosendaal R., Bakker-Woudenberg I.A., van den Berghe-van Raffe, Vink-van den Berg J.C., and Michel M.F. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. Eur. J. Clin. Microbiol. Infect. Dis. 12 (1991) 1019-1025
27. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., and Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 12 (2000) 6166-6173
28. Kuroda E., Kito T., and Yamashita U. Reduced expression of STAT4 and IFN-gamma in macrophages from BALB/c mice. J. Immunol. 11 (2002) 5477-5482
29. Watanabe H., Numata K., Ito T., Takagi K., and Matsukawa A. Innate immune response in Th1- and Th2-dominant mouse strains. Shock 5 (2004) 460-466
30. Cailhier J.F., Partolina M., Vuthoori S., Wu S., Ko K., Watson S., Savill J., Hughes J., and Lang R.A. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J. Immunol. 4 (2005) 2336-2342
31. Wheeler D.S., Lahni P.M., Denenberg A.G., Poynter S.E., Wong H.R., Cook J.A., and Zingarelli B. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 3 (2008) 267-273
32. Sterns T., Pollak N., Echtenacher B., and Mannel D.N. Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect. Immun. 8 (2005) 4905-4912
33. Matsukawa A., Kudo S., Maeda T., Numata K., Watanabe H., Takeda K., Akira S., and Ito T. Stat3 in resident macrophages as a repressor protein of inflammatory response. J. Immunol. 5 (2005) 3354-3359
34. Freudenberg M.A., and Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-d-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 5 (1988) 1352-1357
35. Madonna G.S., and Vogel S.N. Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice. Infect. Immun. 3 (1986) 707-710
36. Xing L., and Remick D.G. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils. Shock 1 (2003) 10-16
37. Brummer E., Sugar A.M., and Stevens D.A. Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect. Immun. 2 (1983) 817-822
38. Sodhi A., Sharma R.K., Batra H.V., and Tuteja U. Mechanism of rLcrV and rYopB mediated immunosuppression in murine peritoneal macrophages. Mol. Immunol. 8 (2004) 767-774
39. Li Q., and Cherayil B.J. Role of Toll-like receptor 4 in macrophage activation and tolerance during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 9 (2003) 4873-4882
40. Hu X., Chen J., Wang L., and Ivashkiv L.B. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 2 (2007) 237-243
41. Lang R., Patel D., Morris J.J., Rutschman R.L., and Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 5 (2002) 2253-2263
42. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., and Volk H.D. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 5 (1995) 1887-1892
43. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., and Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest 5 (1995) 2339-2347
44. Ellaban E., Bolgos G., and Remick D. Selective macrophage suppression during sepsis. Cell Immunol. 1-2 (2004) 103-111
45. Wysocka M., Robertson S., Riemann H., Caamano J., Hunter C., Mackiewicz A., Montaner L.J., Trinchieri G., and Karp C.L. IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J. Immunol. 12 (2001) 7504-7513
46. Fitting C., Dhawan S., and Cavaillon J.M. Compartmentalization of tolerance to endotoxin. J. Infect. Dis. 7 (2004) 1295-1303
47. Neter E. Endotoxins and the immune response. Curr. Top. Microbiol. Immunol. (1969) 82-124
48. Milner K.C. Patterns of tolerance to endotoxin. J. Infect. Dis. Suppl. (1973) 45
49. Lehner M.D., and Hartung T. Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection. Rev. Physiol. Biochem. Pharmacol. (2002) 95-141
50. Colletti L.M., Remick D.G., and Campbell Jr. D.A. LPS pretreatment protects from hepatic ischemia/reperfusion. J. Surg. Res. 3 (1994) 337-343
51. Heemann U., Szabo A., Hamar P., Muller V., Witzke O., Lutz J., and Philipp T. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am. J. Pathol. 1 (2000) 287-293
52. Ackermann M., Reuter M., Flohe S., Bahrami S., Redl H., and Schade F.U. Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J. Endotoxin. Res. 2 (2001) 105-112
53. Severn A., Xu D., Doyle J., Leal L.M., O'Donnell C.A., Brett S.J., Moss D.W., and Liew F.Y. Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. Eur. J. Immunol. 7 (1993) 1711-1714
54. Mason C.M., Dobard E., Summer W.R., and Nelson S. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J. Infect. Dis. 5 (1997) 1293-1302
55. Shahin R.D., Engberg I., Hagberg L., and Svanborg E.C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J. Immunol. 10 (1987) 3475-3480
56. Betjes M.G., Tuk C.W., Struijk D.G., Krediet R.T., Arisz L., Hart M., and Beelen R.H. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J. Infect. Dis. 5 (1993) 1202-1210
57. Abbassi O., Lane C.L., Krater S., Kishimoto T.K., Anderson D.C., McIntire L.V., and Smith C.W. Canine neutrophil margination mediated by lectin adhesion molecule-1 in vitro. J. Immunol. 7 (1991) 2107-2115
58. Wellmer A., Gerber J., Ragheb J., Zysk G., Kunst T., Smirnov A., Bruck W., and Nau R. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect. Immun. 11 (2001) 6881-6886
59. Visser C.E., Tekstra J., Brouwer-Steenbergen J.J., Tuk C.W., Boorsma D.M., Sampat-Sardjoepersad S.C., Meijer S., Krediet R.T., and Beelen R.H. Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin. Exp. Immunol. 2 (1998) 270-275